Spread the love

Prof. C Napoli and the Nobel Prize Winner in Physiology/Medicine (1998)  Prof Ignarro LJ had reported in the high profile journal Proc Natl Acad Sci U S A (2010) that “CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy”  

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Insights into Antiangiogenic therapy: Tumor suppressor ARF impairs VEGF network and angiogenesis via up regulation of its target gene.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Insights into Antiangiogenic therapy: Tumor suppressor ARF impairs the expression of VEGF and its down stream targets that mediate angiogenesis via up regulation of its target gene, 28/March/2014, 6.25 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation


Spread the love